The tyrosine kinase inhibitor masitinib blunts airway inflammation and improves associated lung mechanics in a feline model of chronic allergic asthma.
about
Long-term evaluation of mesenchymal stem cell therapy in a feline model of chronic allergic asthma.Noninvasive Recognition and Biomarkers of Early Allergic Asthma in Cats Using Multivariate Statistical Analysis of NMR Spectra of Exhaled Breath CondensateOpportunities for bead-based multiplex assays in veterinary diagnostic laboratories.Masitinib antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistance.In silico molecular docking analysis of the human Argonaute 2 PAZ domain reveals insights into RNA interference.
P2860
The tyrosine kinase inhibitor masitinib blunts airway inflammation and improves associated lung mechanics in a feline model of chronic allergic asthma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
The tyrosine kinase inhibitor ...... el of chronic allergic asthma.
@en
The tyrosine kinase inhibitor ...... el of chronic allergic asthma.
@nl
type
label
The tyrosine kinase inhibitor ...... el of chronic allergic asthma.
@en
The tyrosine kinase inhibitor ...... el of chronic allergic asthma.
@nl
prefLabel
The tyrosine kinase inhibitor ...... el of chronic allergic asthma.
@en
The tyrosine kinase inhibitor ...... el of chronic allergic asthma.
@nl
P2093
P356
P1476
The tyrosine kinase inhibitor ...... del of chronic allergic asthma
@en
P2093
Amy E DeClue
Carol R Reinero
Leah A Cohn
Tekla M Lee-Fowler
Vamsi Guntur
P304
P356
10.1159/000335122
P50
P577
2012-04-04T00:00:00Z